Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellie Hershberger

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2015
Response to Spellberg and BrassJoseph S Solomkin, Ellie Hershberger, Christian Eckmann
Current Infectious Disease Reports|September 14, 2002
The Role of Fluoroquinolones in the Treatment of Skin and Soft Tissue InfectionMd Rabiul Alam, Ellie Hershberger, Marcus J. Zervos
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2003
Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiologyEllie Hershberger, Susan Donabedian, Konstantinos Konstantinou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2002
Thrombocytopenia associated with linezolid therapyKinan Attassi, Ellie Hershberger, Rabiul Alam, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2012
Pharmacokinetics and safety of intravenous ceftolozane-tazobactam in healthy adult subjects following single and multiple ascending dosesBenjamin Miller, Ellie Hershberger, David Benziger, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2014
Impact of renal function on the pharmacokinetics and safety of ceftolozane-tazobactamMyra Wooley, Benjamin Miller, Gopal Krishna, et al.
Journal of Clinical Pharmacology|September 9, 2014
Population pharmacokinetics of ceftolozane/tazobactam in healthy volunteers, subjects with varying degrees of renal function and patients with bacterial infectionsGurudatt Chandorkar, Alan Xiao, Mohamad-Samer Mouksassi, et al.
The American Journal of Geriatric Pharmacotherapy|March 2, 2011
Safety and clinical outcomes among older adults receiving daptomycin therapy: Insights from a patient registryDaryl D DePestel, Ellie Hershberger, Kenneth C Lamp, et al.
Current Opinion in Critical Care|September 26, 2003
Antimicrobial resistance among gram-positive organisms in the intensive care unitNina M Clark, Ellie Hershberger, Marcus J Zervosc, et al.
The Annals of Pharmacotherapy|July 9, 2009
Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapyPamela A Moise, Ellie Hershberger, Maria I Amodio-Groton, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2015
Response to Spellberg and BrassJoseph S Solomkin, Ellie Hershberger, Christian Eckmann
Current Infectious Disease Reports|September 14, 2002
The Role of Fluoroquinolones in the Treatment of Skin and Soft Tissue InfectionMd Rabiul Alam, Ellie Hershberger, Marcus J. Zervos
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2003
Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiologyEllie Hershberger, Susan Donabedian, Konstantinos Konstantinou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2002
Thrombocytopenia associated with linezolid therapyKinan Attassi, Ellie Hershberger, Rabiul Alam, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2012
Pharmacokinetics and safety of intravenous ceftolozane-tazobactam in healthy adult subjects following single and multiple ascending dosesBenjamin Miller, Ellie Hershberger, David Benziger, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2014
Impact of renal function on the pharmacokinetics and safety of ceftolozane-tazobactamMyra Wooley, Benjamin Miller, Gopal Krishna, et al.
Journal of Clinical Pharmacology|September 9, 2014
Population pharmacokinetics of ceftolozane/tazobactam in healthy volunteers, subjects with varying degrees of renal function and patients with bacterial infectionsGurudatt Chandorkar, Alan Xiao, Mohamad-Samer Mouksassi, et al.
The American Journal of Geriatric Pharmacotherapy|March 2, 2011
Safety and clinical outcomes among older adults receiving daptomycin therapy: Insights from a patient registryDaryl D DePestel, Ellie Hershberger, Kenneth C Lamp, et al.
Current Opinion in Critical Care|September 26, 2003
Antimicrobial resistance among gram-positive organisms in the intensive care unitNina M Clark, Ellie Hershberger, Marcus J Zervosc, et al.
The Annals of Pharmacotherapy|July 9, 2009
Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapyPamela A Moise, Ellie Hershberger, Maria I Amodio-Groton, et al.
Pageof 3